Symbios Dynamic Plasma Activation Technology Being Displayed at WEFTEC 2016

Share Article

Company executives available in the National Science Foundation (NSF) Small Business (SBIR) Program Booth 5725

Symbios Technologies

“The TPR is the first of its kind multi-modal oxidation system that combines electricity and air to achieve both hydrogen- and oxygen-based oxidation chemistries, without added chemicals.” - Justin Bzdek

New Orleans, Louisiana, September 21, 2016 - Symbios Technologies, Inc., a world-leading developer of dynamic aqueous plasma technology platforms, is attending Water Environment Federation Technical Exhibition and Conference (WEFTEC®), in the National Science Foundation (NSF) Small Business Innovation Research (SBIR) Program Pavilion, Booth 5725. Company leadership will be on hand to discuss plasma technology, treatment advantages, and answer collaboration questions.

Symbios is commercializing its Tubular Plasma Reactor™ (TPR4000™) advanced plasma oxidation system for fluid treatment in manufacturing, healthcare, utility, and oil and gas vertical markets. Justin Bzdek, president and CEO, Symbios, said, “The TPR is the first of its kind multi-modal oxidation system that combines electricity and air to achieve both hydrogen- and oxygen-based oxidation chemistries, without added chemicals.”

The Symbios TPR4000 is being advanced under Phase II and Phase IIB supplement NSF SBIR grants along with other grants and industry investment. Through non-thermal, homogeneous, distributed plasma discharge directly in water via its patented, groundbreaking design, the TPR4000 achieves rapid disinfection and reduction of BOD and COD with superior efficacy and lower cost vs. other advanced oxidation processes, without waste streams. Combining the best of UV, ozone, peroxide, and chemical oxidation technologies, the Symbios TPR technology has been tested for efficacy in the food & beverage, healthcare, power plant, fracking wastewater treatment, and other industrial and municipal applications.

“The NSF’s support of science and technology startups with non-dilutive grants through the SBIR program is critical to the success innovative companies like Symbios,” continued Bzdek. “We are honored to be joining other SBIR companies in the NSF Small Business Pavilion at WEFTEC, the Water Environment Federation’s Annual Technical Exhibition and Conference, and other like-minded businesses and professionals at the world’s largest annual water quality exhibition.”

About Symbios Technologies

Symbios Technologies, Inc. is a world-leading developer of dynamic aqueous plasma technology platforms for water treatment, specialty manufacturing, and biotherapeutic applications. The company, working with its university, government and industrial partners is commercializing its disruptive advanced low-cost aqueous plasma oxidation technology, the Symbios Tubular Plasma Reactor™ (TPR4000™), to clean water, preserve the environment, and protect human health as well as improve production economics and sustainability. Symbios Technologies’ modular reactor is low in capital cost, able to replace existing energy-hungry or poor-performing advanced oxidation processes, reduce or eliminate the use of biocides, reduce or eliminate chemical additives, and reduce the overall maintenance cost of water treatment systems, in particular extending the life and reducing fouling of membranes. For more information, go to http://www.symbiosplasma.com/.

Media Contact
Justin Bzdek
President and CEO, Symbios Technologies
info(at)symbiostechnologies(dot)com
970-492-4418

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Justin Bzdek
@SymbiosPlasma
since: 08/2016
Follow >
Visit website